Thromboxane A2 is a lipid-derived signaling hormone involved in platelet activation, blood clot formation, vascular constriction, and hemostatic regulation. TXA2 functions primarily as a pro-aggregatory prostanoid that promotes platelet recruitment and vasoconstriction during vascular injury. By stimulating platelet adhesion and activation, thromboxane A2 helps initiate formation of temporary hemostatic plugs that limit blood loss.
The hormone also influences smooth muscle contraction, pulmonary vascular tone, and communication between activated platelets and vascular tissues. Because TXA2 acts rapidly and locally, it serves as an important mediator linking platelet activation with immediate vascular responses during tissue injury and coagulation signaling.
TXA2 is produced mainly by activated platelets through metabolism of arachidonic acid. Phospholipase A2 releases arachidonic acid from membrane phospholipids, after which cyclooxygenase enzymes generate prostaglandin H2 intermediates. Thromboxane synthase then converts these intermediates into thromboxane A2.
Production increases rapidly when platelets encounter exposed collagen, thrombin signaling, vascular injury, or inflammatory mediators. Because TXA2 is chemically unstable and rapidly degraded into inactive metabolites, its biological effects remain highly localized near activated platelets and injured vascular surfaces.
TXA2 synthesis is regulated by platelet activation pathways, phospholipase signaling systems, oxidative stress, inflammatory mediators, and vascular injury signals. Calcium-dependent platelet activation strongly stimulates thromboxane production during coagulation responses.
TXA2 acts through thromboxane-prostanoid receptors located on platelets and vascular smooth muscle cells. Receptor activation stimulates phospholipase C signaling, intracellular calcium mobilization, vasoconstriction, and platelet aggregation pathways. Prostacyclin and nitric oxide pathways oppose thromboxane signaling to maintain vascular balance. Through these integrated lipid-signaling systems, TXA2 coordinates hemostatic adaptation, platelet communication, vascular contraction, and localized coagulation responses.
Locally acting eicosanoid that signals through TP receptors to increase intracellular Ca²⁺ and Rho/ROCK, driving platelet aggregation and vasoconstriction.
